The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a exciting advance. Unlike subcutaneous injections, this technique offers a less invasive way to provide GLP-1 https://phoenixjffi515286.csublogs.com/48805715/glp-1-patches-a-novel-approach-to-glucose-treatment